Filed: 8/10/2023ACC: 0001910264-23-000005
📋 What this filing means
SR ONE CAPITAL MANAGEMENT, LP filed this quarterly 13F‑HR report disclosing 6 equity positions with a total reported market value of $231.91M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
6
Positions
$231.91M
Total AUM (reported)
24.44M
Total Shares
Allocation by class
COMMON STOCK$124.79M53.8%
COM$107.12M46.2%
Portfolio Concentration
Top 3$196.51M84.7%
4–10$35.40M15.3%
Top 3 weight
84.7%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 24.44M
Sole
Full voting authority
24.44M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole6
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings6
Rows:
ARCELLX INC
SOLEShares3.95M
TypeSH
Market value$124.79M
53.81%
Sole
3.95M
Shared
0.00
None
0.00
DESIGN THERAPEUTICS INC
SOLEShares6.53M
TypeSH
Market value$41.12M
17.73%
Sole
6.53M
Shared
0.00
None
0.00
MINERALYS THERAPEUTICS INC
SOLEShares1.79M
TypeSH
Market value$30.60M
13.19%
Sole
1.79M
Shared
0.00
None
0.00
ARS PHARMACEUTICALS INC
SOLEShares4.01M
TypeSH
Market value$26.89M
11.59%
Sole
4.01M
Shared
0.00
None
0.00
EFFECTOR THERAPEUTICS INC
SOLEShares6.82M
TypeSH
Market value$5.59M
2.41%
Sole
6.82M
Shared
0.00
None
0.00
NKARTA INC
SOLEShares1.33M
TypeSH
Market value$2.92M
1.26%
Sole
1.33M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ARCELLX INCSOLE | COMMON STOCK | 3.95M | SH | $124.79M 53.81% | 3.95M | 0.00 | 0.00 |
DESIGN THERAPEUTICS INCSOLE | COM | 6.53M | SH | $41.12M 17.73% | 6.53M | 0.00 | 0.00 |
MINERALYS THERAPEUTICS INCSOLE | COM | 1.79M | SH | $30.60M 13.19% | 1.79M | 0.00 | 0.00 |
ARS PHARMACEUTICALS INCSOLE | COM | 4.01M | SH | $26.89M 11.59% | 4.01M | 0.00 | 0.00 |
EFFECTOR THERAPEUTICS INCSOLE | COM | 6.82M | SH | $5.59M 2.41% | 6.82M | 0.00 | 0.00 |
NKARTA INCSOLE | COM | 1.33M | SH | $2.92M 1.26% | 1.33M | 0.00 | 0.00 |